Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CD95 APO-1/FAS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 343 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rivas, C; Miller, ARM; Collado, M; Lam, EWF; Apperley, JF; Melo, JV
      BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir

      MOLECULAR THERAPY
    2. Treon, SP; Mitsiades, C; Mitsiades, N; Young, G; Doss, D; Schlossman, R; Anderson, KC
      Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies

      JOURNAL OF IMMUNOTHERAPY
    3. Wagenknecht, B; Roth, W; Gulbins, E; Wolburg, H; Weller, M
      C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis

      CELL DEATH AND DIFFERENTIATION
    4. Fumarola, C; Zerbini, A; Guidotti, GG
      Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis

      CELL DEATH AND DIFFERENTIATION
    5. Bernhard, D; Skvortsov, S; Tinhofer, I; Hubl, H; Greil, R; Csordas, A; Kofler, R
      Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts

      CELL DEATH AND DIFFERENTIATION
    6. Owen-Schaub, L
      Soluble Fas and cancer

      CLINICAL CANCER RESEARCH
    7. Ugurel, S; Rappl, G; Tilgen, W; Reinhold, U
      Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients

      CLINICAL CANCER RESEARCH
    8. Ding, HF; Fisher, DE
      P53, caspase 8, and regulation of apoptosis after ionizing radiation

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    9. Schrantz, N; Bourgeade, MF; Mouhamad, S; Leca, G; Sharma, S; Vazquez, A
      p38-mediated regulation of an Fas-associated death domain protein-independent pathway leading to caspase-8 activation during TGF beta-induced apoptosis in human Burkitt lymphoma B cells BL41

      MOLECULAR BIOLOGY OF THE CELL
    10. Ten Bosch, JV; Otten, J; Thielemans, K
      Autoimmune Lymphoproliferative Syndrome type III, an indefinite disorder

      LEUKEMIA & LYMPHOMA
    11. ten Bosch, JV; Otten, J; Thielemans, K
      Autoimmune lymphoproliferative syndrome type III: An indefinite disorder

      LEUKEMIA & LYMPHOMA
    12. Komata, T; Koga, S; Hirohata, S; Takakura, M; Germano, IM; Inoue, M; Kyo, S; Kondo, S; Kondo, Y
      A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptasegene promoter

      INTERNATIONAL JOURNAL OF ONCOLOGY
    13. Fulda, S; Meyer, E; Friesen, C; Susin, SA; Kroemer, G; Debatin, KM
      Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis

      ONCOGENE
    14. Boldrini, L; Faviana, P; Pistolesi, F; Gisfredi, S; Di Quirico, D; Lucchi, M; Mussi, A; Angeletti, CA; Baldinotti, F; Fogli, A; Simi, P; Basolo, F; Fontanini, G
      Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in nonsmall cell lung cancer

      ONCOGENE
    15. Dunkern, TR; Fritz, G; Kaina, B
      Ultraviolet light-induced DNA damage triggers apoptosis in nucleotide excision repair-deficient cells via Bcl-2 decline and caspase-3/-8 activation

      ONCOGENE
    16. Fulda, S; Kufer, MU; Meyer, E; van Valen, F; Dockhorn-Dworniczak, B; Debatin, KM
      Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer

      ONCOGENE
    17. Lee, SH; Shin, MS; Kim, HS; Lee, HK; Park, WS; Kim, SY; Lee, JH; Han, SY; Park, JY; Oh, RR; Kang, CS; Kim, KM; Jang, JJ; Nam, SW; Lee, JY; Yoo, NJ
      Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma

      ONCOGENE
    18. Liu, BL; Fan, Z
      The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway

      ONCOGENE
    19. Rokhlin, OW; Guseva, N; Tagiyev, A; Knudson, CM; Cohen, MB
      Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis

      ONCOGENE
    20. Suliman, A; Lam, A; Datta, R; Srivastava, RK
      Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

      ONCOGENE
    21. Wosik, K; Becher, B; Ezman, A; Nalbantoglu, J; Antel, JP
      Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes

      GLIA
    22. Vondracek, J; Sheard, MA; Krejci, P; Minksova, K; Hofmanova, J; Kozubik, A
      Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells

      JOURNAL OF LEUKOCYTE BIOLOGY
    23. Seeberger, H; Knorr, C; Muller-Hermelink, HK; Greiner, A
      Impaired CD95 (Fas, APO-1)-mediated apoptosis is a progression factor of early MALT-type lymphomagenesis

      MEDIZINISCHE KLINIK
    24. Lebede, MJ; Ptitsina, JS; Vilkov, SA; Korablev, SB; Novikov, VV
      Membrane and soluble forms of Fas (CD95) in peripheral blood lymphocytes and in serum from burns patients

      BURNS
    25. Rozenfeld-Granot, G; Toren, A; Amariglio, N; Brok-Simoni, F; Rechavi, G
      Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies

      EXPERIMENTAL HEMATOLOGY
    26. Matarrese, P; Testa, U; Cauda, R; Vella, S; Gambardella, L; Malorni, W
      Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis

      BIOCHEMICAL JOURNAL
    27. Fabian, Z; Torocsik, B; Kiss, K; Csatary, LK; Bodey, B; Tigyi, J; Csatary, C; Szeberenyi, J
      Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells

      ANTICANCER RESEARCH
    28. Cullen, K; Davey, R; Davey, M
      The drug resistance proteins, multidrug resistance-associated protein and P-glycoprotein, do not confer resistance to Fas-induced cell death

      CYTOMETRY
    29. Castaneda, F; Kinne, RKH
      Apoptosis induced in HepG2 cells by short exposure to millimolar concentrations of ethanol involves the Fas-receptor pathway

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    30. Roue, G; Lancry, L; Duquesne, F; Salaun, V; Troussard, X; Sola, B
      Upstream mediators of the Fas apoptotic transduction pathway are defectivein B-chronic lymphocytic leukemia

      LEUKEMIA RESEARCH
    31. Cullen, KV; Davey, RA; Davey, MW
      Drug resistance does not correlate with resistance to Fas-mediated apoptosis

      LEUKEMIA RESEARCH
    32. Maeda, T; Kamihira, S
      Apoptosis, part II: The role of mutated Fas genes in tumorigenesis

      ADVANCES IN CLINICAL CHEMISTRY, VOL 36
    33. Zhu, NL; Ware, CF; Lai, MMC
      Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor

      VIROLOGY
    34. Kabra, NH; Kang, CH; Hsing, LC; Zhang, JK; Winoto, A
      T cell-specific FADD-deficient mice: FADD is required for early T cell development

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    35. Zurita, M; Vaquero, J; Zurita, I
      Presence and significance of CD-95 (Fas/APO1) expression after spinal cordinjury

      JOURNAL OF NEUROSURGERY
    36. Wipasa, J; Xu, HJ; Stowers, A; Good, MF
      Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-terminal fragment of merozoite surface protein 1 during malaria infection

      JOURNAL OF IMMUNOLOGY
    37. Besnault, L; Schrantz, N; Auffredou, MT; Leca, G; Bourgeade, MF; Vazquez, A
      B cell receptor cross-linking triggers a caspase-8-dependent apoptotic pathway that is independent of the death effector domain of Fas-associated death domain protein

      JOURNAL OF IMMUNOLOGY
    38. Garban, HJ; Bonavida, B
      Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: A pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells

      JOURNAL OF IMMUNOLOGY
    39. Lee, YJ; Shacter, E
      Fas aggregation does not correlate with Fas-mediated apoptosis

      JOURNAL OF IMMUNOLOGY
    40. Catlett, IM; Xie, P; Hostager, BS; Bishop, GA
      Signaling through MHC class II molecules blocks CD95-induced apoptosis

      JOURNAL OF IMMUNOLOGY
    41. Bennett, MW; O'Connell, J; Houston, A; Kelly, J; O'Sullivan, GC; Collins, JK; Shanahan, F
      Fas ligand upregulation is an early event in colonic carcinogenesis

      JOURNAL OF CLINICAL PATHOLOGY
    42. Feldkamp, J; Pascher, E; Schott, M; Goretzki, P; Seissler, J; Scherbaum, NA
      Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    43. Leroux, E; Auzenne, E; Weidner, D; Wu, ZY; Donato, NJ; Klostergaard, J
      Febrile and acute hyperthermia enhance TNF-induced necrosis of murine L929fibrosarcoma cells via caspase-regulated production of reactive oxygen intermediates

      JOURNAL OF CELLULAR PHYSIOLOGY
    44. Gomez-Angelats, M; Cidlowski, JA
      Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    45. Zheng, LX; Schickling, O; Peter, ME; Lenardo, MJ
      The death effector domain-associated factor plays distinct regulatory roles in the nucleus and cytoplasm

      JOURNAL OF BIOLOGICAL CHEMISTRY
    46. Li, M; Shillinglaw, W; Henzel, WJ; Beg, AA
      The RelA(p65) subunit of NF-kappa B is essential for inhibiting double-stranded RNA-induced cytotoxicity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    47. Nesterov, A; Lu, XJ; Johnson, M; Miller, GJ; Ivashchenko, Y; Kraft, AS
      Elevated Akt activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    48. Sheard, AA
      Ionizing radiation as a response-enhancing agent for CD95-mediated apoptosis

      INTERNATIONAL JOURNAL OF CANCER
    49. Hollander, MC; Sheikh, MS; Yu, K; Zhan, QM; Iglesias, M; Woodworth, C; Fornace, AJ
      Activation of Gadd34 by diverse apoptotic signals and suppression of its growth inhibitory effects by apoptotic inhibitors

      INTERNATIONAL JOURNAL OF CANCER
    50. Hofmann, TG; Moller, A; Hehner, SP; Welsch, D; Droge, W; Schmitz, ML
      CD95-induced JNK activation signals are transmitted by the death-inducing signaling complex (DISC), but not by DAXX

      INTERNATIONAL JOURNAL OF CANCER
    51. Muschen, M; Re, D; Betz, B; Moers, C; Wolf, J; Niederacher, D; Diehl, V; Beckmann, MW
      Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene

      INTERNATIONAL JOURNAL OF CANCER
    52. Park, WS; Lee, JH; Shin, MS; Park, JY; Kim, HS; Kim, YS; Park, CH; Lee, SK; Lee, SH; Lee, SN; Kim, H; Yoo, NJ; Lee, JY
      Inactivating mutations of KILLER/DR5 gene in gastric cancers

      GASTROENTEROLOGY
    53. Decaudin, D; Beurdeley-Thomas, A; Nemati, F; Miccoli, L; Pouillart, P; Bourgeois, Y; Goncalves, RB; Rouillard, D; Poupon, MF
      Distinct experimental efficacy of anti-Fas/APO-1/CD95 receptor antibody inhuman tumors

      EXPERIMENTAL CELL RESEARCH
    54. Hegardt, C; Andersson, G; Oredsson, SM
      Different roles of spermine in glucocorticoid- and Fas-induced apoptosis

      EXPERIMENTAL CELL RESEARCH
    55. Perlman, H; Pagliari, LJ; Nguyen, N; Bradley, K; Liu, HT; Pope, RM
      The Fas-FasL death receptor and P13K pathways independently regulate monocyte homeostasis

      EUROPEAN JOURNAL OF IMMUNOLOGY
    56. Van Huyen, JPD; Sooryanarayana; Delignat, S; Bloch, MF; Kazatchkine, MD; Kaveri, SV
      Variable sensitivity of lymphoblastoid cells to apoptosis induced by Viscum album Qu FrF, a therapeutic preparation of mistletoe lectin

      CHEMOTHERAPY
    57. Seol, DW; Li, JR; Seol, MH; Park, SY; Talanian, RV; Billiar, TR
      Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): Caspase-8 is required for TRAIL-induced apoptosis

      CANCER RESEARCH
    58. Kamihira, S; Yamada, Y; Hirakata, Y; Tomonaga, M; Sugahara, K; Hayashi, T; Dateki, N; Harasawa, H; Nakayama, K
      Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis

      BRITISH JOURNAL OF HAEMATOLOGY
    59. Herr, I; Debatin, KM
      Cellular stress response and apoptosis in cancer therapy

      BLOOD
    60. Secchiero, P; Gonelli, A; Celeghini, C; Mirandola, P; Guidotti, L; Visani, G; Capitani, S; Zauli, G
      Activation of the nitric oxide synthase pathway represents a key componentof tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies

      BLOOD
    61. Moreau, G; Leite-de-Moraes, M; Ezine, S; Di Santo, JP; Dy, M; Schneider, E
      Natural killer cell-dependent apoptosis of peripheral murine hematopoieticprogenitor cells in response to Fas cross-linking: involvement of tumor necrosis factor-alpha

      BLOOD
    62. Ryu, SW; Kim, E
      Apoptosis induced by human fas-associated factor 1, hFAF1, requires its ubiquitin homologous domain, but not the Fas-binding domain

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    63. Jia, L; Patwari, Y; Kelsey, SM; Newland, AC
      TRAIL-induced apoptosis in type I leukemic cells is not enhanced by overexpression of Bax

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    64. Seino, K; Setoguchi, Y; Ogino, T; Kayagaki, N; Akiba, H; Nakano, H; Taniguchi, H; Takada, Y; Yuzawa, K; Todoroki, T; Fukuchi, Y; Yagita, H; Okumura, K; Fukao, K
      Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappa Bactivation

      ANNALS OF SURGERY
    65. Weisberg, S; Ashkenazi, E; Israel, Z; Attia, M; Shoshan, Y; Umansky, F; Brodie, C
      Anaplastic and atypical meningiomas express high levels of Fas and undergoapoptosis in response to Fas ligation

      AMERICAN JOURNAL OF PATHOLOGY
    66. Ferrer, I; Puig, B; Krupinski, J; Carmona, M; Blanco, R
      Fas and Fas ligand expression in Alzheimer's disease

      ACTA NEUROPATHOLOGICA
    67. Kruidering, M; Evan, GI
      Caspase-8 in apoptosis: The beginning of "The End"?

      IUBMB LIFE
    68. Mouawad, R; Antoine, EC; Khayat, D; Soubrane, C
      Effect of endogenous interleukin-6 on Fas (APO-1/CD95) receptor expressionin advanced melanoma patients

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    69. Ricci-Vitiani, L; Conticello, C; Zeuner, A; De Maria, R
      CD95/CD95L interactions and their role in autoimmunity

      APOPTOSIS
    70. Tsokos, GC; Kammer, GM
      Molecular aberrations in human systemic lupus erythematosus

      MOLECULAR MEDICINE TODAY
    71. Wendling, U; Walczak, H; Dorr, J; Jaboci, C; Weller, M; Krammer, PH; Zipp, F
      Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells

      CELL DEATH AND DIFFERENTIATION
    72. Hieronymus, T; Blank, N; Gruenke, M; Winkler, S; Haas, JP; Kalden, JR; Lorenz, HM
      CD 95-independent mechanisms of IL-2 deprivation-induced apoptosis in activated human lymphocytes

      CELL DEATH AND DIFFERENTIATION
    73. Horn, TL; Bhattacharjee, A; Schook, LB; Rutherford, MS
      Altered hepatic mRNA expression of apoptotic genes during dimethylnitrosamine exposure

      TOXICOLOGICAL SCIENCES
    74. Kidd, VJ; Lathi, JM; Teitz, T
      Proteolytic regulation of apoptosis

      SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
    75. Okada, K; Komuta, K; Hashimoto, S; Matsuzaki, S; Kanematsu, T; Koji, T
      Frequency of apoptosis of tumor-infiltrating lymphocytes induced by Fas counterattack in human colorectal carcinoma and its correlation with prognosis

      CLINICAL CANCER RESEARCH
    76. Bellone, G; Smirne, C; Carbone, A; Mareschi, K; Dughera, L; Farina, EC; Alabiso, O; Valente, G; Emanuelli, G; Rodeck, U
      Production and pro-apoptotic activity of soluble CD95 ligand in pancreaticcarcinoma

      CLINICAL CANCER RESEARCH
    77. Eerola, AK; Soini, Y; Paakko, P
      A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma

      CLINICAL CANCER RESEARCH
    78. Ferreira, CG; Tolis, C; Span, SW; Peters, GJ; van Lopik, T; Kummer, AJ; Pinedo, HM; Giaccone, G
      Drug-induced apoptosis in lung cancer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway

      CLINICAL CANCER RESEARCH
    79. Dunican, AL; Leuenroth, SJ; Ayala, A; Simms, HH
      CXC chemokine suppression of polymorphonuclear leukocytes apoptosis and preservation of function is oxidative stress independent

      SHOCK
    80. Von Herbay, A; Rudi, J
      Role of apoptosis in gastric epithelial turnover

      MICROSCOPY RESEARCH AND TECHNIQUE
    81. Embade, N; Valeron, PF; Aznar, S; Lopez-Collazo, E; Lacal, JC
      Apoptosis induced by Rac GTPase correlates with induction of FasL and ceramides production

      MOLECULAR BIOLOGY OF THE CELL
    82. Aten, J; Roos, A; Claessen, N; Schilder-Tol, EJM; Ten Berge, IJM; Weening, JJ
      Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    83. Kobayashi, N; Takada, Y; Hachiya, M; Ando, K; Nakajima, N; Akashi, M
      TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: Important role of protein stabilization

      CYTOKINE
    84. Owen-Schaub, L; Chan, H; Cusack, JC; Roth, J; Hill, LL
      Fas and Fas ligand interactions in malignant disease (Review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    85. Chaudhary, PM; Eby, MT; Jasmin, A; Kumar, A; Liu, L; Hood, L
      Activation of the NF-kappa B pathway by Caspase 8 and its homologs

      ONCOGENE
    86. del Arroyo, AG; Gil-Lamagniere, C; Lazaro, I; de Marco, MC; Layunta, I; Silva, A
      Involvement of p53 and interleukin 3 in the up-regulation of CD95 (APO-1/Fas) by X-ray irradiation

      ONCOGENE
    87. Lee, SW; Ko, YG; Bang, S; Kim, KS; Kim, S
      Death effector domain of a mammalian apoptosis mediator, FADD, induces bacterial cell death

      MOLECULAR MICROBIOLOGY
    88. Otsuki, T; Hata, H; Harada, N; Matsuzaki, H; Yata, K; Wada, H; Yawata, Y; Ueki, A; Yamada, O
      Cellular biological differences between human myeloma cell lines KMS-12-PEand KMS-12-BM established from a single patient

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    89. Burgert, HG; Blusch, JH
      Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses

      VIRUS GENES
    90. Shain, KH; Landowski, TH; Buyuksal, I; Cantor, AB; Dalton, WS
      Clonal variability in CD95 expression is the major determinant in Fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line

      LEUKEMIA
    91. Irisarri, M; Plumas, J; Bonnefoix, T; Jacob, MC; Roucard, C; Pasquier, MA; Sotto, JJ; Lajmanovich, A
      Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line

      LEUKEMIA
    92. Aquaro, S; Panti, S; Caroleo, MC; Balestra, E; Cenci, A; Forbici, F; Ippolito, G; Mastino, A; Testi, R; Mollace, V; Calio, R; Perno, CF
      Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes

      JOURNAL OF LEUKOCYTE BIOLOGY
    93. Debatin, KM
      Activation of apoptosis pathways by anticancer treatment

      TOXICOLOGY LETTERS
    94. Lasham, A; Lindridge, E; Rudert, F; Onrust, R; Watson, J
      Regulation of the human fas promoter by YB-1, Pur alpha and AP-1 transcription factors

      GENE
    95. Bruserud, O; Ulvestad, E
      Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    96. Feuk, L; Prince, JA; Breen, G; Emahazion, T; Carothers, A; Clair, DS; Brookes, AJ
      Apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: finding of a positive association for a polymorphism in the TNFRSF6 gene

      HUMAN GENETICS
    97. Bolstad, AI; Wargelius, A; Nakken, B; Haga, HJ; Jonsson, R
      Fas and Fas ligand gene polymorphisms in primary Sjogren's syndrome

      JOURNAL OF RHEUMATOLOGY
    98. Hisahara, S; Takano, R; Shoji, S; Okano, H; Miura, M
      Role of caspase-1 subfamily in cytotoxic cytokine-induced oligodendrocyte cell death

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    99. Labroille, G; Dumain, P; Lacombe, F; Belloc, F
      Flow cytometric evaluation of Fas expression in relation to response and resistance to anthracyclines in leukemic cells

      CYTOMETRY
    100. Kaplowitz, N
      Mechanisms of liver cell injury

      JOURNAL OF HEPATOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/21 alle ore 19:54:58